In cohorts from high/intermediate and low burden settings, TB incidence rates generally increased with decreasing current CD4 counts and CD4 count at cART initiation, more so with CD4 counts less than 200 cells/μl (Table 3). This evidence concerns the gene CD4 and tuberculosis.